insights_auto
Why is DFTX down 10.62%?
Dive Deeperchevron_right
DFTX:NASDAQ
Definium Therapeutics Inc
$32.47
arrow_downward
-10.62%(-3.86) 1D
$32.60
arrow_upward
+0.40% (+0.13)bedtimeAfter hours
Closed: Nov 2, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$36.51
High
$36.84
Low
$31.61
Mkt. cap
4.36B
Avg. vol.
2.02M
Volume
0.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.19
Shares outstanding
134.37M
No. of employees
106
Open
$36.51
High
$36.84
Low
$31.61
Mkt. cap
4.36B
Avg. vol.
2.02M
Volume
0.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.19
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
marketscreener.com
·
27 minutes ago
S&P 500 index fell sharply after Stockholm exchange close Monday
BigGo Finance
·
13 minutes ago
Nasdaq Vice Chairman Warns: Taiwan Stocks Climb to World's Fourth Largest, but 79% AI Exposure Tops the Globe
Quantisnow
·
50 minutes ago
Pershing Square USA, Ltd. Releases Third Quarter 2026 Portfolio Review
MarketWatch
·
8 hours ago
Nasdaq Inc. stock outperforms competitors on strong trading day
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com